drugset / Trial / NCT00432432

Combination Methotrexate and Infliximab

NCT00432432

Phase 4 Completed 38 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Combination Methotrexate and Infliximab:Influence of immunogenicity on the efficacy of infliximab in patients with Ankylosing Spondylitis.

Timeline

Start
2005-02
Primary completion
2006-08
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Infliximab Monoclonal antibody 5 mg/kg
Comparator Methotrexate Small molecule 15 mg